Passive immunization during pregnancy for congenital cytomegalovirus infection.

By G. Nigro, S. Adler, R. La Torre, A. Best. New England Journal of Medicine, 2005

695 citations recorded by the source corpus.

Subfields: Epidemiology, Infectious Diseases, Rheumatology

View Paper: https://www.semanticscholar.org/paper/1a1ad461c1a4fc029bfbf175b7fa9c98783545e4

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. R. Khanna
2. M. Cannon
3. T. Crough

Citations in the corpus

• Immunobiology of Human Cytomegalovirus: from Bench to Bedside (2009, background): “Clinically, the passive administration of intravenous immunoglobulins containing high levels of HCMV antibodies (HCMV-specific hyperimmune globulin) can protect against disease in newborns, resulting from the infusion of HCMVcontaining blood (250), and can increase virus-specific immunoglobulin G co”
• The “Silent” Global Burden of Congenital Cytomegalovirus (2013, background): “(HIG) in women with primary infection during pregnancy (167).”
• Review and meta‐analysis of the epidemiology of congenital cytomegalovirus (CMV) infection (2007, background): “A number of other promising interventions have been proposed for congenital CMV, such as hand hygiene education to prevent primary infection among pregnant women [5], prenatal maternal screening to identify candidates for hyperimmune globulin [6] or antiviral therapies R E V I E W”